The Incidence, Clinical Characteristics and Outcome of Infective Endocarditis Among Intravenous Drug Abusers Versus Non-Drug Abusers.
NCT06194409 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2024-06-25
Summary
We aim to describe the incidence of IVDA among patients presented with IE, describe their clinical, psychiatric and microbiological characteristics in comparison to non - IVDA, as well as the rate and types of complications and outcome, and responsiveness to medical treatment or surgical intervention.
Conditions
- Infective Endocarditis
Interventions
- DIAGNOSTIC_TEST
-
Echocardiography, Urine analysis , blood culture
All patients will be investigated by ECG, Urine analysis, blood culture , Echocardiography
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Yehia Kish · Assiut University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-05
- Primary Completion
- 2025-05-31
- Completion
- 2025-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
Trends of Acute Intoxication in Poison Control Centre
NCT05098418 ·Status: UNKNOWN
-
Prevalence of New Psychoactive Substances Use
NCT03695419 ·Status: UNKNOWN
-
A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users
NCT02144415 ·Status: COMPLETED ·Phase: PHASE1
-
Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers
NCT03481192 ·Status: UNKNOWN ·Phase: NA
-
Marijuana Drug Discrimination and Self-Administration
NCT00943930 ·Status: COMPLETED
-
Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments
NCT07333131 ·Status: RECRUITING
-
Outcomes of Antipsychotic Medication Used in the Emergency Department
NCT02504450 ·Status: COMPLETED
-
Correlation of Genetic Variations With Clinical Response in Substance Use Disorder
NCT05833399 ·Status: UNKNOWN
-
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000255 ·Status: COMPLETED ·Phase: PHASE2
-
Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment
NCT04343339 ·Status: COMPLETED
-
Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT00000258 ·Status: COMPLETED ·Phase: NA
-
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252 ·Status: COMPLETED ·Phase: PHASE2
-
Single and Repeat Doses of DMT in Healthy Subjects
NCT05559931 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Pattern of Acute Antipsychotic Drug- Toxicity in Children
NCT06125275 ·Status: NOT_YET_RECRUITING
-
Drug Discrimination in Methadone-Maintained Humans Study 3
NCT01068847 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
NCT04266288 ·Status: COMPLETED ·Phase: PHASE4
-
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
NCT03648684 ·Status: COMPLETED ·Phase: NA
-
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
NCT00329394 ·Status: SUSPENDED ·Phase: PHASE3
-
Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users
NCT02682225 ·Status: COMPLETED ·Phase: PHASE1
-
A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medication
NCT05731999 ·Status: COMPLETED ·Phase: NA
-
SBI for PSM and PSD
NCT06923384 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder
NCT04866043 ·Status: COMPLETED
-
Behavior Brain Responses
NCT03964350 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Measuring Acute Drug Demand in Humans
NCT05829655 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
Quantification of Drugs and Their Degradation Products
NCT01828372 ·Status: UNKNOWN ·Phase: NA